← FDA Drug Approvals (Drugs@FDA)

DAPTOMYCIN

NDA · New Drug Application · Sponsor: MAIA PHARMS INC · Approved 2024-11-21

Drug application

FDA Application #

NDA217630

Application type

New Drug Application

Brand name

DAPTOMYCIN

Generic name

DAPTOMYCIN

Active ingredients

DAPTOMYCIN

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

MAIA PHARMS INC

Manufacturer

Par Health USA, LLC

First approval

2024-11-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown